Ancilia Biosciences
PrivateLast Round
Seed Round
Apr 6, 2026
Total Funding Raised
$7.73M
Momentum Score
50 /100
Company Overview
Ancilia Biosciences is a biotechnology company developing a new class of live biotherapeutics and other microbial products with immunity to key viral pathogens by harnessing the natural power of CRISPR.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ancilia Biosciences Comps
Public and private peers based on sector, stage, and business model.
Ancilia Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Apr 6, 2026 | ||||
| Grant | Oct 23, 2024 | ||||
| Grant | Oct 23, 2024 | ||||
| Seed | Jul 17, 2024 | ||||
| Grant | Aug 3, 2021 |
Key People
Founding team and executive leadership
Ancilia Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Safar Partners | Seed |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| Spacecadet Ventures | Seed |
| Zubi Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 6, 2026
$10M Seed Round raised.
- Jul 17, 2024
$4.2M round led by Safar Partners.
Ancilia Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ancilia Biosciences's valuation, stock price, and market status.
